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Abstract. The value of a semi-quantitative scoring of the filarial antigen test (Binax Now Filariasis card test, ICT)
results was evaluated during a field survey in the Republic of Congo. One hundred and thirty-four (134) of 774 tests
(17.3%) were clearly positive and were scored 1, 2, or 3; and 11 (1.4%) had questionable results. Wuchereria bancrofti
microfilariae (mf) were detected in 41 of those 133 individuals with an ICT test score ³ 1 who also had a night blood smear;
none of the 11 individuals with questionable ICT results harbored night mf. Cuzick’s test showed a significant trend for
higher microfilarial densities in groups with higher ICT scores (P < 0.001). The ICT scores were also significantly correlated
with blood mf counts. Because filarial antigen levels provide an indication of adult worm infection intensity, our results
suggest that semi-quantitative reading of the ICT may be useful for grading the intensity of filarial infections in individuals
and populations.
The current methods of choice for diagnosis of active infec-
tions with Wuchereria bancrofti, the main agent of lymphatic
filariasis (LF), are based on detection of microfilaria (mf) or
circulating filarial antigens (CFA) in blood. Although anti-
genemia can be detected by enzyme-linked immunosorbent
assay (ELISA), field studies and filariasis elimination programs
generally use a point-of-care immunochromatographic card test
(ICT) (Binax Now Filariasis ICT test, Alere, Portland, ME).1
Several publications have addressed the issue of the choice
of diagnostic tools for use in different phases of LF control
programs.2–4 Before the initiation of mass drug administra-
tion (MDA), the simplest method for assessing LF endemicity
in an area is to measure the proportion of individuals with
CFA, using the ICT test. Night blood testing of persons with
positive ICT tests can be used to estimate the mf rate in the
population. After MDA has been initiated, antigen testing
can also be used to assess the impact of MDA.4 However, as
the primary objective of the control programs is to remove mf
(required for transmission of the parasite), and as filarial anti-
gen rates decrease more slowly than the microfilaria rates,5
it is also useful to follow mf rates during MDA programs.6
Another key factor determining the duration of the control
programs is the impact of MDA on the lifespan of adult
W. bancrofti.7,8 Two methods have been used to evaluate this,
namely ultrasonography, which permits visualization of motile
adult worms (the “filarial dance sign”) in some infected individ-
uals, and quantitative CFA testing.9–13 However, ultrasonogra-
phy for LF is not sensitive for diagnosis of filarial infections and
it requires expensive equipment and highly trained personnel.
Quantitative CFA testing also requires highly trained personnel
and significant laboratory infrastructure. Thus, these techniques
are not feasible for routine use in LF control programs. There-
fore, this study was designed to explore the value of using
a scoring system for ICT tests as a semi-quantitative method
for assessing W. bancrofti adult worm loads in individuals and
in populations.
An LF survey was conducted in October 2012 in the village
of Se´ke´ Pembe´, located in the Bouenza division of the Republic
of Congo. Se´ke´ Pembe´ had not receivedMDA for LF, but some
village residents had received treatment with mebendazole for
intestinal worm infections. A detailed census of the population
had been performed 1 month before the LF survey, and all
persons 5 years of age and above were invited to be tested for
W. bancrofti infection. Blood was collected by finger prick, and
ICT tests were performed according to the manufacturer’s
instructions. The ICT tests were read in 10 minutes by a single
trained operator (author MB). Intensity of the test (“T”) line
was scored as follows: (0) indicating no visible “T” lines; (0.5)
for questionable “T” lines or very faint shadows requiring the
opinion of a second examiner; (1) for clearly visible “T” lines
but weaker than the control line; (2) for “T” lines that were
approximately as dark as the control line; and (3) for cards
with a “T” line darker than the control line.
Subjects with ICT scores > 0 were called back for a second
blood sampling (thick smear for detection of mf) between the
hours of 10:00 PM and 1:00 AM. Blood was collected using a
capillary tube, and two blood smears (volume 70 mL) were
prepared for each subject. On the next day, the blood smears
were dehemoglobinized, stained with Giemsa, and read by two
experienced microscopists (authors JB andMB). As loiasis and
Mansonella perstans filariasis are also endemic in the area,
special attention was paid to identify the species of each mf
present in the thick smears, and counts were recorded sepa-
rately for each species. The mf density was defined as the
highest count of the two slides and expressed as mf per
70 microliters of blood (mf/70 mL). The maximum ratio
between the higher and lower mf count from two slides from
individuals was 2.9 (22 and 64 mf/70 mL). The median ratio was
1.5 (interquartile range [IQR]: 1.2–1.7). When not specified,
all results presented below will refer only toW. bancrofti mf.
The distribution of the ICT scores was compared between
microfilaremic and amicrofilaremic subjects using theWilcoxon
test. Mean microfilarial densities were compared between ICT
score groups using the Cuzick’s test for trend14; the correlation
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between ICT scores and mf density was assessed using the
Spearman’s rank correlation coefficient. All analyses were per-
formed using STATA 12.1 (StataCorp, College Station, TX).
This study was approved by the ethical committee of the
Republic of Congo (Ministry of Public Health). Written
informed consent was obtained from all adults participating
in the study and from parents or legal guardians of minors.
The ICT tests were performed on 774 of the 876 individuals
³ 5 years of age and recorded during the preliminary census.
A total of 145 individuals had an ICT score > 0; 11 had scores of
0.5 (1.4% of the population tested), 85 had scores of 1 (11%),
35 had scores of 2 (4.5%), and 14 had scores of 3 (1.8%).
All but one of the individuals with ICT scores > 0 had night
blood collected for mf testing. Only 3 and 2 patients had Loa
loa or M. perstans mf in the blood smears, respectively.
Wuchereria bancroftimicrofilaremia was detected in 41 individ-
uals. This number represented 5.3% (41 of 773) of the popula-
tion tested, 28.5% (41 of 144) of those ICT scores > 0, and
30.8% (41 of 133) of those with ICT scores > 0.5. None of the
individuals with ICT of 0.5 was microfilaremic. The proportions
of people with microfilaremia were 10.7%, 57.1%, and 85.7%
in people with ICT scores of 1, 2, and 3, respectively. The
distribution of the ICT scores among the microfilaremic and
amicrofilaremic ICT positive subjects is presented in Figure 1;
the median score was significantly higher in microfilaremics
than in individuals with no mf (Wilcoxon test; P < 0.001).
The arithmetic mean mf density in those who were
microfilaremic was 44.1 mf/70 mL. Figure 2 shows the distribu-
tions of the microfilarial densities for each ICT score group.
The overall (i.e., including amicrofilaremic individuals) mean
mf densities in score groups 1, 2, and 3 were 1.6 (SD: 5.2), 22.2
(SD: 41.7), and 64.6 mf/70 mL (SD: 87.2), respectively (Figure 2,
right side). The mean mf densities among microfilaremic
individuals were 14.1 (SD: 8.1) in group 1, 38.8 (SD: 49.3) in
group 2, and 75.4 mf/70 mL (SD: 90.0) in group 3 (Figure 2,
left side). Cuzick’s test showed a highly significant trend for
higher microfilarial densities in groups with higher ICT scores
(P < 0.001 for the entire study population and P = 0.021 in those
who were microfilaremic). The correlation, at the individual
level, between ICT scores (for those with scores ³ 1) and mf
density was positive and significant (r = 0.61, P < 0.001 for all
subjects with scores ³ 1; and r = 0.37, P = 0.0187 for subjects
withmicrofilaremia).
Circulating filarial antigen levels are believed to be corre-
lated with adult worm counts in humans with bancroftian fila-
riasis.1,9 Though it is impossible to accurately determine the
number of macrofilariae in vivo, this assertion is supported by
studies that have shown a relationship between antigen levels
and microfilarial densities in mf-positive individuals before
treatment,1,15–22 and a relationship between antigen levels
and microfilarial densities with the frequency of detection
of worm nests by ultrasonography.10–12,16,23
The original AD12 ELISA and the Og4C3-based TropBio
ELISA tests are useful for quantitating filarial antigenemia.1,9,24
However, these tests require highly trained personnel and sig-
nificant laboratory infrastructure, and they are usually not prac-
tical for use by national LF elimination programs.13 The fact
that the ICT test can provide a semi-quantitative assessment
of antigen levels (and perhaps relative adult worm burdens)
may be helpful to LF elimination programs as an indicator
of infection intensity in populations. Similarly, changes in mean
ICT scores could provide an indication of the impact of MDA
on adult worms in endemic communities. Decreases in mean
ICT scores among those with positive antigen tests after the first
rounds of MDA might provide a more accurate indication
of the success of MDA than changes in antigen prevalence rates.
Our study also provided new data on the issue of equivocal
ICT card test results. Because all 11 of the people with ICT
scores of 0.5 (very faint shadow lines) were amicrofilaremic,
our study suggests that cards with very faint shadow lines
should be considered to be negative for filarial antigenemia.
The ICT filarial antigen tests are widely performed before,
during, and after MDA programs. Our results suggest that it is
useful to score these tests and that test scores can be used
together with antigen prevalence data. A recently published
study used a similar scoring system to evaluate the Alere
Filariasis Test Strip that is expected to replace the ICT test
Figure 1. Frequency distributions of the immunochromatographic
card test (ICT) scores in microfilaremic (striped boxes) and
amicrofilaremic (white boxes) subjects with positive ICT test results.
Figure 2. Distribution of Wuchereria bancrofti microfilarial
densities by immunochromatographic card test (ICT) score for micro-
filaremic subjects (left panel) and for all ICT positive subjects (right
panel). Horizontal lines represent arithmetic means and 95% confi-
dence intervals.
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in the near future.25 Although the Test Strip was more sensitive
than the ICT test in that study, antigen scores for blood sam-
ples that were positive by either test were highly correlated.
Note that there is no additional cost associated with scoring
filarial antigen tests, and scores can be written directly on the
cards. Antigen test score data from other endemic areas with
different infection rates and treatment histories will help to
confirm the practical value of antigen test scoring for LF elimi-
nation programs.
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